Study in Patients With Breast Cancer Leptomeningeal Metastasis

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

Traditional clinical trials in patients with breast cancer leptomeningeal disease (LMD) are challenging as patients often have a rapidly progressive course and prognosis is poor, making meeting standard eligibility difficult. Furthermore, there is limited information about the biology of LMD. The investigators thus propose a study that is as inclusive as possible, which will allow the investigators to collect biospecimens and clinical outcomes to learn more about LMD biology, but still potentially provide benefit for patients, by providing patients rapid diagnostics and multi-disciplinary treatment recommendations.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Kobieta lub mężczyzna w wieku 18 lat lub starszy
  • Historia raka piersi (dowolny typ)
  • Podejrzenie przerzutów raka piersi do opon mózgowych potwierdzone objawami, wynikami badań obrazowych lub analizy płynu mózgowo-rdzeniowego
  • Wcześniejsze przerzuty do ośrodkowego układu nerwowego są dopuszczalne
  • Wystarczająca sprawność fizyczna pacjenta (ocena ECOG ≤3 lub skala Karnofskiego ≥60)

✗ Disqualifies

  • Podejrzenie przerzutów do mózgu pochodzących z białaczki, chłoniaka lub innego nowotworu
  • Pacjent nie kwalifikuje się do leczenia przerzutów do opon mózgowych

Simplified criteria — AI translation

Trial details

Minimum age
18 Weeks
Last updated (source)
November 28, 2025
Sex
No restrictions

Locations (2)

Sibley Memorial Hospital

Washington D.C., United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Baltimore, United States

Trial contact

Sidney Kimmel Cancer Center Clinical Research Office

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.